Items where Author is "Kopelman, Peter"

Kopelman, PG, Bryson, A, Hickling, R, Rissanen, A, Rossner, S, Troubro, S and Valensi, P (2007) Cetilistat (ATL -962), a novel lipase inhibitor: a 12 week randomised, placebo-controlled study of weight reduction in obese patients. International Journal of Obesity, 31 (3). pp. 494-499.

Kopelman, PG (2005) Clinical treatment of obesity: are drugs and surgery the answer? Proceedings of Nutrition Society, 64 (1). pp. 65-71.

Kopelman, PG (2004) The metabolic syndrome as a clinical problem. Nestle Nutr Workshop Ser: Clin Perform Programme, 9. pp. 77-92.

Kopelman, PG and Grace, C (2004) New thoughts on managing obesity. Gut, 53 (7). pp. 1044-1053.

Kopelman, PG and Rahilly, S (2004) Obesity. In: Oxford Textbook of Medicine 4th Edition. Oxford University Press. ISBN 0198570139

Chowdhury, TA, Grace, C and Kopelman, PG (2003) Preventing diabetes in South Asians: Too little action and too late. British Medical Journal, 327 (7423). pp. 1059-1060.

Kopelman, PG (2003) The fat of the land: The science of fat and the future of thin. In: UNSPECIFIED UNSPECIFIED, pp. 378-379. ISBN 0028-0836

van Baak, MA, van Mil, E, Astrup, AV, Finer, N, Van Gaal, LF, Hilsted, J, Kopelman, PG, Rossner, S, James, WP and Saris, WH (2003) Leisure-time activity is an important determinant of long-term weight maintenance after weight loss in the Sibutramine Trial on Obesity Reduction and Maintenance (STORM trial). American Journal of Clinical Nutrition, 78 (2). pp. 209-214.

Dacre, J and Kopelman, PG (2002) Handbook of Clinical Skills. Manson Publishing Ltd. ISBN 187454557X

Kopelman, PG and Lennard-Jones, J (2002) Nutrition and patients: a doctor's responsibility. Clinical Medicine, 2 (5). pp. 391-394.

O'Rahilly, S and Kopelman, PG (2002) Obesity and Satiety. In: Comprehensive Clinical Endocrinology. Harcourt Health Science. ISBN 072343185X

Uchegbu, EC and Kopelman, PG (2002) Cardiovascular risks in obesity. Journal of Endocrinol Invest, 25 (10). pp. 915-918.

Hansen, D, Astrup, AV, Toubro, S, Finer, N, Kopelman, PG, Hilsted, J, Rossner, S, Saris, W, Van Gaal, L and James, W (2001) Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial. Sibutramine Trial of Obesity Reduction and Maintenance. International Journal of Obesity, 25 (4). pp. 496-501.

Kesaniemi, YK, Danforth Jr., E, Jensen, MD, Kopelman, PG, Lefebvre, P and Reeder, BA (2001) Dose-response issues concerning physical activity and health: an evidence-based symposium. Medicine and Science in Sports and Exercise, 33 (Suppl 6).

Kopelman, PG (2001) Developing an action plan for obesity education. International Journal of Obesity, 25 (Suppl 4).

Kopelman, PG and Finer, N (2001) Reply: Is obesity a disease? International Journal of Obesity, 25 (10). pp. 1405-1406.

Wellmer, A, Misra, VP, Sharief, MK, Kopelman, PG and Anand, P (2001) A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy. Peripher Nerv Syst, 6 (4). pp. 204-210.

Prentice, A, Uchegbu, E and Kopelman, PG Treatment of Obesity. In: Encyclopedia of Nutrition Second Edition. Elsevier Press. (In Press)